Work

Effect of JAK2 SNP rs2274472 on outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.4_suppl.595

Authors: Martin D. Berger, Sebastian Stintzing, Volker Heinemann, Dongyun Yang, Shu Cao, Yan Ning, Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Roel Gopez, Diana L. Hanna, Wu Zhang, Heinz-Josef Lenz

Institutions: University of Southern California, USC Norris Comprehensive Cancer Center, Ludwig-Maximilians-Universität München, The Cancer Institute Hospital, Japanese Foundation For Cancer Research

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600722726

Cites:

Cited by: 1

Related to: 10